Frailty and Age as Predictors of Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock

M Wasim Ahmadzai1, Joakim Bo Kunkel1, Peter Laursen Graversen1

  • 1Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

JACC. Advances
|September 18, 2025
PubMed

Insights

Frailty and advanced age significantly increase mortality risk in patients with acute myocardial infarction complicated by cardiogenic shock (AMICS). Identifying these factors is crucial for improving patient outcomes in AMICS.

Area of Science:

  • Cardiology
  • Gerontology
  • Critical Care Medicine

Background:

  • Acute myocardial infarction complicated by cardiogenic shock (AMICS) has a high in-hospital mortality rate (~50%).
  • Frailty is a known predictor of adverse outcomes but is understudied in AMICS.

Purpose of the Study:

  • To assess the independent and combined impact of frailty and age on mortality in AMICS patients.
  • To identify high-risk patient subgroups within AMICS.

Main Methods:

  • Retrospective observational study of 1,716 AMICS patients (RETROSHOCK cohort, 2010-2017).
  • Frailty assessed using Hospital Frailty Risk Score (≥5 defined as frail).
  • Patients stratified by age (≥70 vs <70 years) and analyzed in 5 age groups; mortality assessed at 30 days, 1 year, and 10 years.

Main Results:

  • Frailty present in 22% of patients; 30-day mortality was 65% in frail vs 51% in non-frail (P < 0.001).
  • Patients aged ≥80 years had 82% 30-day mortality; adjusted HR for death was 9.18 compared to non-frail patients <50 years.
  • Combined frailty and age (≥70 years) showed 73% 30-day and 82% 10-year mortality; frailty independently predicted mortality (aHR: 1.84).

Conclusions:

  • Frailty and age are significant, independent predictors of mortality in AMICS.
  • These factors can identify high-risk patients requiring targeted interventions.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
710
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218